Higher Dosing 'Difficult to Straddle'

Chicago - Escalating doses of an antibody to CTLA-4 in conjunction with a peptide vaccine showed the induction of antigen-specific immune responses and potential evidence of autoimmunity in patients with stage III/IV resected melanoma, according to Jeffrey M. Weber, M.D., Ph.D.

Related Videos
Related Content

Treating Body Dysmorphic Disorder in Cosmetic Patients

March 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Study Finds Successful Switching Strategy for Patients with Psoriasis After Suboptimal Response

March 20th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Establishing a Culture of Respect: Responding to Patient-Initiated Harassment

March 20th 2023

Advancements in Understanding the Skin's Microbiomes

March 20th 2023

Treating Body Dysmorphic Disorder in Cosmetic Patients

March 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Study Finds Successful Switching Strategy for Patients with Psoriasis After Suboptimal Response

March 20th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Establishing a Culture of Respect: Responding to Patient-Initiated Harassment

March 20th 2023

Advancements in Understanding the Skin's Microbiomes

March 20th 2023

Treating Body Dysmorphic Disorder in Cosmetic Patients

March 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Study Finds Successful Switching Strategy for Patients with Psoriasis After Suboptimal Response

March 20th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Establishing a Culture of Respect: Responding to Patient-Initiated Harassment

March 20th 2023

Advancements in Understanding the Skin's Microbiomes

March 20th 2023
© 2023 MJH Life Sciences

All rights reserved.